Hims & Hers HealthXSWX:HIMS 81 EV-to-FCF is 119.24 as of Jul. 03, 2026, which is 257% above its 10-year median of 33.40. GuruFocus rates XSWX:HIMS with a GF Score™ of 81/100 and a GF Value™ of CHF32.30. The stock has 3 warning signs investors should review. Among 562 Drug Manufacturers companies, Hims & Hers Health ranks worse than 90.75% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Hims & Hers Health's Enterprise Value is CHF7,201.36 Mil.
Hims & Hers Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was CHF60.40 Mil. Therefore, Hims & Hers Health's EV-to-FCF for today is 119.24.
The historical rank and industry rank for Hims & Hers Health's EV-to-FCF or its related term are showing as below:
XSWX:HIMS'
s EV-to-FCF Range Over the Past 10 Years
Min: -379.11 Med: 33.4 Max: 164.4
Current: 147.34
During the past 7 years, the highest EV-to-FCF of Hims & Hers Health was 164.40. The lowest was -379.11. And the median was 33.40.
XSWX:HIMS's EV-to-FCF is ranked worse than 90.75% of 562
companies
in the Drug Manufacturers industry
Industry Median: 20.525
vs XSWX:HIMS: 147.34
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hims & Hers Health (XSWX:HIMS) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Hims & Hers Health's PE Ratio (TTM) for today is calculated as:
Hims & Hers Health's share price for today is CHF29.895.
Hims & Hers Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Hims & Hers Health EV-to-FCF Related Terms
Hims & Hers Health EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Hims & Hers Health's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Hims & Hers Health's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hims & Hers Health EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Hims & Hers Health's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Hims & Hers Health's EV-to-FCF falls into.
Hims & Hers Health's current Enterprise Value is CHF7,201.36 Mil.
Hims & Hers Health's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF60.40 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hims & Hers Health (XSWX:HIMS) has a EV-to-FCF of 119.24 as of Jul. 03, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hims & Hers Health and its competitors. This is 257% above median its historical median of 33.40. According to the industry distribution chart, Hims & Hers Health ranks #510 out of 562 companies in the Drug Manufacturers industry, placing it in the top 90.7%.
Is Hims & Hers Health's EV-to-FCF too high?
Hims & Hers Health's current EV-to-FCF of 119.24 is 257% above median its 10-year median of 33.40. The Drug Manufacturers industry median EV-to-FCF is 20.53. Hims & Hers Health's value of 119.24 is 481% above this industry median. Based on the distribution chart, Hims & Hers Health ranks #510 out of 562 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Hims & Hers Health has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Hims & Hers Health's EV-to-FCF compare to ?
According to the Drug Manufacturers industry distribution chart, Hims & Hers Health ranks #510 out of 562 companies for EV-to-FCF. This places Hims & Hers Health in the lower half of its industry. The industry median EV-to-FCF is 20.53. Hims & Hers Health's value of 119.24 is 481% above this benchmark. While the company's 10-year median is 33.40 vs. the industry median of 20.53, Hims & Hers Health has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.53, based on 562 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hims & Hers Health's current EV-to-FCF of 119.24 is 481% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Hims & Hers Health and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hims & Hers Health's current EV-to-FCF is 119.24, which is 257% above median its own 10-year median of 33.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hims & Hers Health stock overvalued right now?
Hims & Hers Health (XSWX:HIMS) has a current EV-to-FCF of 119.24. The stock's GF Value™ is CHF32.30, compared to a current price of CHF29.90 — trading 7.4% below its estimated fair value. The current EV-to-FCF is 119.24, which is 257% above median its 10-year median of 33.40 and 481% above the Drug Manufacturers industry median of 20.53. Hims & Hers Health's overall GF Score™ is 81/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Hims & Hers Health (XSWX:HIMS), the current EV-to-FCF is 119.24 as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hims & Hers Health (XSWX:HIMS) Overvalued in 2026?
Based on GuruFocus' analysis, Hims & Hers Health stock appears to be undervalued.
The current stock price of CHF29.90 is trading 7.4% below its estimated GF Value™ of CHF32.30.
Key valuation signals for XSWX:HIMS:
EV-to-FCF: 119.24 (257% above median its 10-year median of 33.40)
GF Value™: CHF32.30 vs. price of CHF29.90 (7.4% below fair value)
Industry Position: 481% above the Drug Manufacturers median (#510 of 562)
No single metric tells the full story. See the XSWX:HIMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
81GF Score
Get the complete analysis for XSWX:HIMS
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:HIMS has been successfully added to your 
